Eli Lilly expects to have data from a late-stage trial involving orforglipron by April. This weight loss pill helped patients lose nearly 15% of their weight in a phase 2 trial. Lilly has been a ...

Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands Mounjaro and Zepbound, in India by 2025. However, regulatory approvals are ...

The multiple heat settings on a good heating pad could answer all your aches and pains. These are CNET staff's favorite picks that provide soothing relief. James has been writing about technology ...

Who is Lily? That’s the question NCIS fans have had since the Season 21 finale, and well, it turns out we’re not the only ones wondering about that young girl Parker (Gary Cole) saw while he ...

RIDGELAND, Miss. (WJTV) – Kristin Lape, with The Lily Pad, joined us to talk about the nonprofit café in Ridgeland. The café will train people with intellectual and developmental disabilities ...

Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters. In a study sponsored by Lilly ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Ken Fisher's other top stock picks. Ken Fisher is the founder of Fisher Asset Management ...

90 Day Fiance: The Other Way Season 6 star Lily has confirmed what Josh revealed earlier this week: They are no longer together and are headed for divorce. Lily shared the news on TikTok in an ...

FORT COLLINS — Lilly Downs rolled out of bed in her new apartment and began setting up her morning’s IV fluids, which flow from a tube in her chest into her bloodstream to keep the 20-year-old ...